Literature DB >> 15033802

Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.

Patrice Delobel1, Christel Mailliot, Malika Hamdane, Anne-Véronique Sambo, Séverine Bégard, Anne Violleau, André Delacourte, Luc Buée.   

Abstract

Many neurodegenerative disorders referred to as "tauopathies" are characterized by the accumulation and aggregation of Tau proteins into filaments. In these pathologies, Tau proteins are hyperphosphorylated and also abnormally phosphorylated. Moreover, they differ from each other by the preferential aggregation of isoforms exhibiting either three microtubule-binding repeats (3R) or four repeats (4R) Tau. To investigate the effects of an intracellular accumulation of Tau, we stably transfected neuroblastoma cell line SY5Y with either 3R or 4R Tau. Our data showed that an increase in intracellular Tau expression has led to their hyperphosphorylation. Conversely, an abnormal Tau phosphorylation and/or aggregation were never observed. Furthermore, SY5Y cells transfected with 4R Tau showed an increased susceptibility to cell death. Finally, in apoptotic conditions, Tau proteins were degraded at their carboxy terminus by caspase, leading to an apparent decrease in Tau phosphorylation in this region. Because truncated Tau generated during apoptosis are not commonly found in Tau aggregates, apoptotic processes may not be of interest in neurofibrillary degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15033802     DOI: 10.1196/annals.1299.115

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 2.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

3.  Implicating calpain in tau-mediated toxicity in vivo.

Authors:  James B Reinecke; Sarah L DeVos; James P McGrath; Amanda M Shepard; Dustin K Goncharoff; Don N Tait; Samantha R Fleming; Michael P Vincent; Michelle L Steinhilb
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

4.  Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes.

Authors:  Alexis Bretteville; Kunie Ando; Antoine Ghestem; Anne Loyens; Séverine Bégard; Jean-Claude Beauvillain; Nicolas Sergeant; Malika Hamdane; Luc Buée
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

5.  Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.

Authors:  K Schindowski; K Belarbi; A Bretteville; K Ando; L Buée
Journal:  Genes Brain Behav       Date:  2008-02       Impact factor: 3.449

6.  The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells.

Authors:  Magdalena Maj; Gregor Hoermann; Sazan Rasul; Wolfgang Base; Ludwig Wagner; Johannes Attems
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.